These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34287756)

  • 1. Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence.
    Moran A; Mashele N; Mvududu R; Gorbach P; Bekker LG; Coates TJ; Myer L; Joseph Davey D
    AIDS Behav; 2022 Jan; 26(1):205-217. PubMed ID: 34287756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa.
    Joseph Davey DL; Mvududu R; Mashele N; Lesosky M; Khadka N; Bekker LG; Gorbach P; Coates TJ; Myer L
    J Int AIDS Soc; 2022 Feb; 25(2):e25866. PubMed ID: 35138678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa.
    Beesham I; Dovel K; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    AIDS Behav; 2022 Sep; 26(9):3079-3087. PubMed ID: 35316471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Alcohol Use Is Associated With Increased Pre-exposure Prophylaxis (PrEP) Continuation and Adherence Among Pregnant and Postpartum Women in South Africa.
    Miller AP; Shoptaw S; Moucheraud C; Mvududu R; Essack Z; Gorbach PM; Myer L; Davey DLJ
    J Acquir Immune Defic Syndr; 2023 Mar; 92(3):204-211. PubMed ID: 36413977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence challenges with daily oral pre-exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study.
    Joseph Davey D; Nyemba DC; Castillo-Mancilla J; Wiesner L; Norman J; Mvududu R; Mashele N; Johnson LF; Bekker LG; Gorbach P; Coates TJ; Myer L
    J Int AIDS Soc; 2022 Dec; 25(12):e26044. PubMed ID: 36480171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme.
    Kinuthia J; Pintye J; Abuna F; Mugwanya KK; Lagat H; Onyango D; Begnel E; Dettinger J; Baeten JM; John-Stewart G;
    Lancet HIV; 2020 Jan; 7(1):e38-e48. PubMed ID: 31813837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "I had Made the Decision, and No One was Going to Stop Me" -Facilitators of PrEP Adherence During Pregnancy and Postpartum in Cape Town, South Africa.
    Joseph Davey DL; Knight L; Markt-Maloney J; Tsawe N; Gomba Y; Mashele N; Dovel K; Gorbach P; Bekker LG; Coates TJ; Myer L
    AIDS Behav; 2021 Dec; 25(12):3978-3986. PubMed ID: 34085132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of HIV Preexposure Prophylaxis Among Young Pregnant Women from Rural KwaZulu-Natal, South Africa.
    Vazquez L; Moll AP; Kacin A; Ndlovu NE; Shenoi SV
    AIDS Patient Care STDS; 2019 May; 33(5):214-219. PubMed ID: 31067125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care testing for sexually transmitted infections and HIV pre-exposure prophylaxis among pregnant women in South Africa, 2021-2022: randomised controlled trial.
    de Voux A; Nyemba DC; Silliman M; Mashele N; Mvududu R; Myer L; Joseph Davey D
    Sex Transm Infect; 2024 Feb; 100(2):77-83. PubMed ID: 38124133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa.
    Khadka N; Gorbach PM; Nyemba DC; Mvududu R; Mashele N; Javanbakht M; Nianogo RA; Aldrovandi GM; Bekker LG; Coates TJ; Myer L; Joseph Davey DL
    Front Reprod Health; 2023; 5():1224474. PubMed ID: 37795521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial.
    Joseph Davey DL; Dovel K; Cleary S; Khadka N; Mashele N; Silliman M; Mvududu R; Nyemba DC; Coates TJ; Myer L
    BMC Public Health; 2022 Jul; 22(1):1306. PubMed ID: 35799121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of assessing and addressing mental health barriers to PrEP use during pregnancy and postpartum in sub-Saharan Africa: state of the science and research priorities.
    Stanton AM; O'Cleirigh C; Knight L; Davey DLJ; Myer L; Joska JA; Mayer KH; Bekker LG; Psaros C
    J Int AIDS Soc; 2022 Oct; 25(10):e26026. PubMed ID: 36251124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Risk Factors of PrEP Use Stigma Among Adolescent Girls and Young Women in Johannesburg, South Africa and Mwanza, Tanzania Participating in the EMPOWER Trial.
    Munthali RJ; Stangl AL; Baron D; Barré I; Harvey S; Ramskin L; Colombini M; Naicker N; Kapiga S; Delany-Moretlwe S;
    AIDS Behav; 2022 Dec; 26(12):3950-3962. PubMed ID: 35776254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship Between HIV Pre-exposure Prophylaxis Stigma and Treatment Adherence Among Current HIV Pre-exposure Prophylaxis Users in the Southeastern U.S.
    Van Gerwen OT; Yigit I; Crockett KB; Turan B
    AIDS Behav; 2023 May; 27(5):1478-1485. PubMed ID: 36209179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences on PrEP Uptake and Adherence Among South African Women During Periconception and Pregnancy: A Qualitative Analysis.
    Wyatt MA; Pisarski EE; Kriel Y; Smith PM; Mathenjwa M; Jaggernath M; Smit JA; Matthews LT; Ware NC
    AIDS Behav; 2023 Jan; 27(1):208-217. PubMed ID: 35771311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-Care Sexually Transmitted Infection Testing Improves HIV Preexposure Prophylaxis Initiation in Pregnant Women in Antenatal Care in Cape Town, South Africa, 2019 to 2021.
    de Voux A; Mvududu R; Happel A; Jaspan HB; Nyemba DC; Mashele N; Myer L; Davey DLJ
    Sex Transm Dis; 2023 Feb; 50(2):92-97. PubMed ID: 36630416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the potential impact of providing preexposure prophylaxis in pregnant and breastfeeding women in South Africa.
    Joseph Davey DL; Bekker LG; Gomba Y; Coates T; Myer L; Johnson LF
    AIDS; 2019 Jul; 33(8):1391-1395. PubMed ID: 30950882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda.
    Kagaayi J; Batte J; Nakawooya H; Kigozi B; Nakigozi G; Strömdahl S; Ekström AM; Chang LW; Gray R; Reynolds SJ; Komaketch P; Alamo S; Serwadda D
    J Int AIDS Soc; 2020 Aug; 23(8):e25588. PubMed ID: 32785976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.